Simris Group AB (publ), through its wholly owned subsidiary Simris Biologics GmbH, has signed a non-binding concept sheet with a EU based biopharmaceutical company specializing in the development of ...

CenExel is pleased to announce the appointment of Samantha Stellenberg as the Interim Chief Operating Officer at CenExel Atlanta GA. With nearly two decades of experience in clinical research and an ...

Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that its Idylla™ EGFR Mutation Test has received the European Union (EU) Technical Documentation ...

Qlucore, a leading provider of powerful visualization-based bioinformatics data analysis tools, announces the launch of a new version of Qlucore Omics Explorer in the cloud. The new release includes ...

New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...

The global Dental Consumables Market is expected to grow at a rate of 6% to reach $25 billion by 2026. The growing prevalence of oral health problems and dental disorders, the rising geriatric ...

The Global Dermal Fillers Market valued at $2.8 billion in 2021, is set to witness a healthy growth rate of 10% by 2026. ‘Covid-19-Zoom-Boom Effect’, an increasing influence of social media in ...

The Global Hyperbaric Oxygen Therapy Devices Market is expected to grow at a rate of 6.5% by 2026.Growing number of acute and chronic infections, adoption of HBOT in cosmetic procedures and wound ...

The Global Vaccine Storage Equipment Market is expected to grow at a rate of 8-10% by 2026. Rising number of infectious diseases and immunological disorders, large-scale implementation of vaccination ...

Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells receive, process and respond to these signals has been extremely hard to ...

Sanofi announced today that the U.S. FDA has granted orphan drug designation to rilzabrutinib for the treatment of sickle ...

The global cellulite treatment market is expected to be valued at USD 3.67 billion in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period from 2024 to 2034, eventually exceeding ...